Por: ABC7 Health March 17, 2023
Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1.The move follows similar ones by Eli Lilly and Novo Nordisk this month. The three companies dominate the global insulin market.Insulin manufacturers have come under increased public and government pressure to lower... + full article
Forbes USA Business March 17, 2023
Topline Pharmaceutical giant Sanofi announced Thursday it will cut the price of its most commonly prescribed insulin by 78% and cap the monthly cost at $35, becoming the latest drug maker—behind Eli Lilly and Novo Nordisk—to slash insulin costs this month, amid growing calls... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
How the Other Insulin Makers Are Responding to Eli Lilly’s Price Cap | Time
WPTV USA Nation March 17, 2023
Amid pressure from both the public and the Biden administration, a third insulin maker announced it is capping insulin prices. The announcement this week by Sanofi means the three largest insulin producers in the world have instituted price caps in recent... + más
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk | Forbes
Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35 | ABC7
CNBC USA Health March 16, 2023
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, January 9, 2020.George Frey Reuters on Thursday said it's planning to cut the U.S. price of its most popular insulin drug by 78% and cap monthly out-of-pocket... + más
Time USA Health March 03, 2023
Facing pressure to curb diabetes-treatment costs, Eli Lilly & Co. announced on March 1 that it is slashing insulin prices and immediately capping the out-of-pocket cost of all of its insulins at $35 a month. President Joe Biden, who made insulin costs a last month, praised the... + más
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions | NBC News
Eli Lilly caps out-of-pocket costs for insulin effective immediately | Fox Business
Fox Business USA Business March 02, 2023
Arkansas Attorney General Leslie Rutledge provides insight into the conditions at the southern border as Title 42 is set to end and suing major pharma companies over raising the price of insulin. Eli Lilly is capping out-of-pocket costs for its insulin at $35 for patients,... + más
Eli Lilly To Lower Insulin Prices And Introduce A $35 Out-Of-Pocket Monthly Cap For Commercially Insured And Uninsured Diabetics | Forbes
Forbes USA Tech March 01, 2023
This photo shows a vial of Eli Lilly's Humalog insulin. Eli Lilly will cut prices for several of its ... [+] insulin products later this year and introduce a monthly cap of $35 in out-of-pocket costs for commercially insured and uninsured patients. The moves announced March... + más
Eli Lilly plans to slash some insulin prices, expand cost cap | Portland Press Herald
CBS News USA Health October 18, 2022
About 1.3 million Americans rationed their prescribed doses of insulin last year to save money, a pattern one doctor said threatens the health — and even the lives — of people with diabetes. Many people are taking less than the recommended amount of insulin as the cost of... + más
3 in 10 uninsured Americans with diabetes may ration insulin: Study | ABC News
1.3 million Americans with diabetes rationed insulin in the past year, study finds | CNN
About iurex | Privacy Policy | Disclaimer |